logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Sequenom, Inc.


USPTO Granted Patents = 190

% Expired Patents = 19.5



Trademarks = 6

Forward Citations = 9,528

Loading Chart...
Loading Chart...

132 inventors (with patents filed for the assignee):

goldMedal Cosmin Deciu (35 out of 36 patents)

silverMedal Mathias Ehrich (34 out of 38 patents)

bronzeMedal Charles Cantor (28 out of 101 patents)

4.  Hubert Köster (25 out of 26 patents)

5.  Dirk Johannes Van Den Boom (21 out of 33 patents)

6.  Zeljko Dzakula (21 out of 24 patents)

7.  Sung Kyun Kim (17 out of 17 patents)

8.  Andreas Braun (17 out of 17 patents)

9.  Hubert Koster (16 out of 17 patents)

10.  Daniel P Little (15 out of 16 patents)

11.  Hubert Köster (12 out of 18 patents)

12.  Amin R Mazloom (11 out of 15 patents)

13.  Taylor Jacob Jensen (10 out of 11 patents)

14.  Franz Hillenkamp (9 out of 12 patents)

15.  Christian Jurinke (8 out of 8 patents)


Core Competencies:
Non-Invasive Testing
Fetal Nucleic Acid
Genetic Variations
Methylation Enrichment
Aneuploidy Detection
Nucleic Acid Analysis
Copy Number Alterations
Biological Molecules
Sequence Read Quantification
Solid Supports
Genetic Mosaicism
Polymorphic Markers

190 patents:

1. 12706175 - Methods and processes for non-invasive assessment of genetic variations (2026-08-11),
2. 12637714 - METHODS, AND SYSTEMS TO DETECT TRANSPLANT REJECTION (2026-05-26),
3. 12630865 - PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION (2026-05-19),
4. 12534758 - Methods and processes for non-invasive assessment of genetic variations (2026-01-27),
5. 12480159 - Compositions containing identifier sequences on solid supports for nucleic acid sequence analysis (2025-11-25),
6. 12437838 - Methods and processes for non-invasive analysis of cell-free fetal nucleic acid according to sequence read quantifications for chromosomes 13, 18, and 21 (2025-10-07),
7. 12421550 - Methods and processes for assessment of genetic mosaicism (2025-09-23),
8. 12410475 - Methods and processes for non-invasive assessment of genetic variations (2025-09-09),
9. 12400736 - Methods and processes for non-invasive estimation of fetal fraction (2025-08-26),
10. 12198786 - Methods and processes for non-invasive assessment of genetic variations (2025-01-14),
11. 12176067 - Methods and processes for non-invasive assessment of genetic variations (2024-12-24),
12. 12112832 - Methods and processes for non-invasive assessment of genetic variations (2024-10-08),
13. 12077752 - Nucleic acid preparation compositions and methods (2024-09-03),
14. 12071654 - Capture probe-based library normalization (2024-08-27),
15. 11952569 - Methods and compositions for the extraction and amplification of nucleic acid from a sample (2024-04-09),
Sequenom, Inc., based in San Diego, CA, specializes in genetic testing technologies that focus on non-invasive prenatal testing. The company is recognized for its advancements in analyzing fetal nucleic acids, enabling the detection of genetic variations and conditions such as aneuploidy. Their innovative approaches include methylation enrichment and nucleic acid analysis, which contribute to the understanding of copy number alterations and other biological molecules. Sequenom's work is pivotal in enhancing prenatal care through safer and more accurate testing methods.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

190 Patents

#28 in San Diego, CA

#470 in California

#2,161 in US

#4,426 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Sequenom, Inc.

Forward Citations = 9,528

132 inventors:

goldMedal Cosmin Deciu (35 out of 36 patents)

silverMedal Mathias Ehrich (34 out of 38 patents)

bronzeMedal Charles Cantor (28 out of 101 patents)

4.  Hubert Köster (25 out of 26 patents)

5.  Dirk Johannes Van Den Boom (21 out of 33 patents)

Please report any incorrect information to [email protected]
Loading…